Skip to content
★ Sign in to follow
PM
Total declarations
17
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 05 Mar 2019 for BIOGEN INC..

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Paul McKenzie: trading record in brief

This profile gathers the share dealings of Paul McKenzie in Biogen Inc. The record holds 17 filings, for trades running from 1 March 2017 to 1 March 2019.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 5 March 2019, reports a share grant of €119k in Biogen Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Paul McKenzie

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◇
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    568 shares0Common StockSEC:0001127602-19-009924:1
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    135,311 USD13SEC
    405 shares@ US$334.1015.9% of flowCommon StockSEC:0001127602-19-009924:0
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    84,527 USD12SEC
    253 shares@ US$334.109.9% of flowCommon StockSEC:0001127602-19-009924:2
  • ◇
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    1,448 shares0Common StockSEC:0001127602-19-007260:0
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    214,035 USD14SEC
    643 shares@ US$332.8725.3% of flowCommon StockSEC:0001127602-19-007260:1
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    121,383 USD12SEC
    380 shares@ US$319.4312.0% of flowCommon StockSEC:0001127602-19-006088:1
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    172,173 USD13SEC
    539 shares@ US$319.4317.0% of flowCommon StockSEC:0001127602-19-006088:3
  • ◇
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    1,263 shares0Common StockSEC:0001127602-19-006088:0
  • ◇
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    1,799 shares0Common StockSEC:0001127602-19-006088:2
  • ◇
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    532 shares0Common StockSEC:0001127602-18-010088:1
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    114,352 USD12SEC
    405 shares@ US$282.3510.0% of flowCommon StockSEC:0001127602-18-010088:0
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    66,917 USD12SEC
    237 shares@ US$282.355.8% of flowCommon StockSEC:0001127602-18-010088:2
  • ◇
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    1,472 shares0Common StockSEC:0001127602-18-007206:0
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    132,326 USD12SEC
    442 shares@ US$299.3811.3% of flowCommon StockSEC:0001127602-18-007206:1
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    46,042 USD11SEC
    157 shares@ US$293.264.6% of flowCommon StockSEC:0001127602-17-010305:1
  • ◇
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    481 shares0Common StockSEC:0001127602-17-010305:0
  • ◆
    EVP Pharmaceutical Oper & TechExecutivesBiogen Inc.
    0SEC
    2,730 shares0Common StockSEC:0001127602-17-010305:2

17 of 17 declarations